Package 0024-5761-05

{"route": ["SUBCUTANEOUS"], "spl_id": "50747fb3-464f-4b71-bd57-5bf163c43d76", "openfda": {"nui": ["M0011417", "N0000175453", "N0000178480", "M0160181", "N0000020058"], "unii": ["2ZM8CX04RZ", "74O62BB01U"], "rxcui": ["1858995", "1859000"], "spl_set_id": ["4bba538b-cf7c-4310-ae8f-cb711ed21bcc"], "pharm_class_cs": ["Insulin [CS]", "Glucagon-Like Peptide 1 [CS]"], "pharm_class_epc": ["Insulin Analog [EPC]", "GLP-1 Receptor Agonist [EPC]"], "pharm_class_moa": ["Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]"], "manufacturer_name": ["Sanofi-Aventis U.S. LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 SYRINGE in 1 CARTON (0024-5761-01)  / 3 mL in 1 SYRINGE", "package_ndc": "0024-5761-01", "marketing_start_date": "20161121"}, {"sample": false, "description": "5 SYRINGE in 1 CARTON (0024-5761-05)  / 3 mL in 1 SYRINGE (0024-5761-02)", "package_ndc": "0024-5761-05", "marketing_start_date": "20161121"}], "brand_name": "Soliqua 100/33", "product_id": "0024-5761_50747fb3-464f-4b71-bd57-5bf163c43d76", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["GLP-1 Receptor Agonist [EPC]", "Glucagon-Like Peptide 1 [CS]", "Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]", "Insulin Analog [EPC]", "Insulin [CS]"], "product_ndc": "0024-5761", "generic_name": "insulin glargine and lixisenatide", "labeler_name": "Sanofi-Aventis U.S. LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Soliqua 100/33", "active_ingredients": [{"name": "INSULIN GLARGINE", "strength": "100 U/mL"}, {"name": "LIXISENATIDE", "strength": "33 ug/mL"}], "application_number": "BLA208673", "marketing_category": "BLA", "marketing_start_date": "20161121", "listing_expiration_date": "20261231"}